High prices leave 10 000 breast cancer patients without life-saving treatment
The prices charged by health multinational Roche were ‘significantly out of kilter’, the Competition Commission found
Severin Schwan
You are viewing the M&G archive site.
Go to mg.co.za →
The Mail & Guardian has a new home.
Visit the new mg.co.za →